Disease Progression  >>  Halaven (eribulin mesylate)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Halaven (eribulin mesylate) / Eisai
NCT01837095: Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer

Completed
1
54
US, Europe
POL6326
Polyphor Ltd.
Metastatic Breast Cancer
08/18
08/18

Download Options